Galbraith Kenneth bought ZYME
January 12, 2026 · Form 4 insider transaction
Galbraith Kenneth bought 144,000 shares of Zymeworks Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
144,000
Price
$0.00
Total value
N/A
InsiderGalbraith Kenneth
RoleOfficer, Director
CompanyZymeworks Inc. (ZYME)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 12, 2026
Filing dateJanuary 12, 2026
Shares owned after144,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of common stock.; RSUs vest in four equal annual installments beginning on first anniversary of grant date.